BioVoice News November 2017 Issue 6 Volume 2 | Page 32

How much of your customers are in the rural areas as against the cities? How are you trying to reach out? The diagnostics market in 2014 stood at around $5 billion, wherein pathology was 70% and radiology was 30%. Our estimate is that overall market growth would be 15- 17% and pathology testing would be growing at 20-22%. Currently, we cater to Delhi NCR region covering Delhi, Noida, Greater Noida, Gurgaon, end of FY 17-18. The Ghaziabad and Faridabad. company aims to add over 200 labs and over 3,000 How is Healthians doing phlebotomists across 30 in terms of revenue and cities by the end of 2019. the response from the customer base? What are your immediate and long- term goals? We have done 7x growth in revenues during FY 16- 17 and tracking to further growth of 4x in revenues during FY 17-18 while 95% of the revenues still are from Delhi NCR. Having set stable operations in Delhi/NCR, the company plans to expand to the other major cities including Mumbai, Bengaluru, along with expanding to five identified Tier II cities by 32 BioVoiceNews | November 2017 billion, wherein pathology was 70% and radiology was 30%. Our estimate is that overall market growth would be 15-17% and pathology testing would be We would like to increase growing at 20-22%. By our base to 1 million that logic, today the customers in Delhi NCR in overall market would be next 6-8 months and $8 Billion and pathology would be doing over testing would be close to 3,00,000 booking every $6 billion. Home-based month by end of next testing does not have any financial year. significant share, but is a rapidly expanding What is the current market size of Indian segment. medical diagnostics We estimate the market size to double in 5-6 years. industry and which India’s medical spend is are the growth approximately $160 drivers for the billion, out of which 50% sector? is spent on curing and The diagnostics market in managing lifestyle 2014 stood at around $5 diseases. With rising